Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based study
Open Access
- 9 July 2013
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 268
Abstract
Background: Sizwe Tropical Diseases Hospital is the only specialized Hospital for the management of multidrug-resistant (MDR)-TB and extensively drug-resistant (XDR)-TB cases in Gauteng Province. In South Africa, there is a mismatch between numbers of individuals with a laboratory diagnosis of drug-resistant tuberculosis (TB) and those being referred for the initiation of specialist treatment. We determined reasons for non-referral of MDR-TB and XDR-TB cases. Methods: We conducted a descriptive questionnaire-based study amongst provincial primary health care facilities (PHC) and hospitals providing routine care for (drug-susceptible) TB, regarding specialist care referral of patients whose TB culture and susceptibility testing confirmed MDR-TB or XDR-TB diagnoses in the first half of 2008. Results: In total 148 cases were analyzed; 144/148 (97%) had MDR-TB and 4/148 (3%) had XDR-TB. The main reason for non-referral to specialist care was loss to follow up, for patients diagnosed in-hospital (74/97; 76%) as well as in PHCs (11/21; 52%). Nineteen per cent (18/97) of patients diagnosed in hospital versus 33% (7/21) of patients diagnosed in PHCs deceased before referral. Conclusions: A significant problem in the fight to control DR-TB is follow-up after diagnosis with a delay in patient tracing. TB Focal Points in hospital need to be strengthened in order to improve on patient follow-up and care, and tracer teams should assist with community follow up.Keywords
This publication has 9 references indexed in Scilit:
- Drug-resistant and extensively drug-resistant tuberculosis in southern AfricaCurrent Opinion in Pulmonary Medicine, 2010
- HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health responseThe Lancet, 2009
- The Global Burden of Tuberculosis — Combating Drug Resistance in Difficult TimesNew England Journal of Medicine, 2009
- High Tuberculosis and HIV Coinfection Rate, JohannesburgEmerging Infectious Diseases, 2007
- Cost-Effectiveness of Treating Multidrug-Resistant TuberculosisPLOS Medicine, 2006
- Patient and health care system delays in the start of tuberculosis treatment in NorwayBMC Infectious Diseases, 2006
- Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional studyBMC Infectious Diseases, 2005
- Cost effectiveness analysis of strategies for tuberculosis control in developing countriesBMJ, 2005
- A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UKThorax, 2002